ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

NEOG BREAKING NEWS: A Securities Fraud Class Action has been filed against Neogen Corporation -- Investors are Notified to Contact BFA Law to Potentially Recover Investment Losses

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Neogen Corporation (NASDAQ: NEOG) and certain of the Company’s senior executives for potential violations of the federal securities laws.

If you invested in Neogen, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/neogen-corporation-class-action-lawsuit.

Investors have until September 16, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Neogen stock. The case is pending in the U.S. District Court for the Western District of Michigan and is captioned Operating Engineers Construction Industry and Miscellaneous Pension Fund v. Neogen Corporation, et al., No. 25-cv-00802.

Why Was Neogen Sued for Securities Fraud?

Neogen is a food safety company that manufactures and markets products and services dedicated to food and animal safety. In September 2022, Neogen merged with the Food Safety Division of the 3M Company (“3M”) in a $5.3 billion deal. During the relevant period, Neogen touted the integration process and stated the company made “huge strides” in 2024 that allowed the company to “refocus that energy and time from integration efforts to efficiency and growth efforts[.]”

In truth, as alleged, Neogen knew integration inefficiencies would necessitate a goodwill impairment and would impact capital expenditures, revenues, and EBITDA margins.

The Stock Declines as the Truth Is Revealed

On January 10, 2025, Neogen revealed that it was forced to take a $461 million non-cash goodwill impairment charge related to the 3M acquisition and cut its 2025 full year revenue and EBITDA guidance. On this news, the price of Neogen stock declined $0.71 per share, or over 5%, from a closing price of $13.07 per share on January 8, 2025, to $12.36 per share on January 10, 2025.

On April 9, 2025, the company again cut its fiscal year 2025 revenue and EBITDA outlook and announced an additional $100 million in capital expenditures as a result of lowered adjusted EBITDA and a pull-forward of integration-related capital expenditures. The company also revealed its CEO would be stepping down. On this news, the price of Neogen stock declined $2.02 per share, or over 28%, from a closing price of $7.04 per share on April 8, 2025, to $5.02 per share on April 9, 2025.

Then, on June 4, 2025, Neogen revealed that expected EBITDA would fall to “around the high-teens,” a significant decline from the prior quarter’s profit margin of 22% due to “elevated inventory write-offs.” On this news, the price of Neogen stock declined $1.04 per share, or over 17%, from a closing price of $6.00 per share on June 3, 2025, to $4.96 per share on June 4, 2025.

Click here for more information: https://www.bfalaw.com/cases-investigations/neogen-corporation-class-action-lawsuit.

What Can You Do?

If you invested in Neogen you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases-investigations/neogen-corporation-class-action-lawsuit

Or contact:

Ross Shikowitz

ross@bfalaw.com

212-789-3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases-investigations/neogen-corporation-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Neogen Corporation (NASDAQ: NEOG) and certain of the Company’s senior executives for potential violations of the federal securities laws.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.